[Worldwide, cervical cancer remains the second most frequent malignancy. The estimated number of new cases is 450,000 per year. Approximately 80% of affected women live in developing countries where access to cervical screening programmes is limited. In Europe, more than 12,800 women die each year from this preventable disease. Human papilloma virus (HPV) infection has been proved to be a potential cause of cervical cancer. Secondary screening decreases the morbidity and mortality of the disease, but does not prevent HPV infection. HPV-DNA can be detected in 90-100% of preinvasive and invasive cervical cancer cases. Trials assessing prophylactic anti-HPV vaccination have confirmed that the vaccination is a suitable method for the primary prevention of precancer lesions and cervical cancer.]

[Worldwide, cervical cancer remains the second most frequent malignancy. The estimated number of new cases is 450,000 per year. Approximately 80% of affected women live in developing countries where access to cervical screening programmes is limited. In Europe, more than 12,800 women die each year from this preventable disease. Human papilloma virus (HPV) infection has been proved to be a potential cause of cervical cancer. Secondary screening decreases the morbidity and mortality of the disease, but does not prevent HPV infection. HPV-DNA can be detected in 90-100% of preinvasive and invasive cervical cancer cases. Trials assessing prophylactic anti-HPV vaccination have confirmed that the vaccination is a suitable method for the primary prevention of precancer lesions and cervical cancer.]

[The high incidence of oral carcinoma in Hungary is attributed primarily to tobacco and alcohol use. Recently, however, a series of publications suggested a role for humán papillomavirus in the development of oral carcinoma. For this reason we reviewed the literature regarding the associations of human papillomavirus with oral carcinoma and its preblastomatoses. We also overviewed research aiming to develop reliable methods for early diagnosis that are also suitable for screening. Early diagnosis and treatment may significantly improve the prospects of the patient. In addition, the addition of already available human papilloma virus vaccines into national vaccination programs and the extension of vaccination for both sexes may decrease the prevalence of oral carcinoma associated with human papillomavirus infection that primarily affects younger populations.]